SCHEMBL18725184

SCHEMBL18725184

C=CC=NN(C)C(=N)Nc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ TGM2 P21980 1/20 0.39
▸ CYP1A2 P05177 2/20 0.36
▸ TAS2R38 P59533 1/20 0.34
▸ NAPRT Q6XQN6 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2001630 0.72 TAS2R38 (0.46) SMN1; SMN2TAS2R38NAPRTHSD17B10MEN1
SCHEMBL18725181 0.69 TGM2 (0.42) SMN1; SMN2TGM2CYP1A2TAS2R38HSD17B10
SCHEMBL9113008 0.67 HTT (0.49) SMN1; SMN2TAS2R38NAPRTHSD17B10MEN1
SCHEMBL20143330 0.67 TGM2 (0.43) SMN1; SMN2TGM2CYP1A2TAS2R38NAPRT
SCHEMBL14868313 0.66 TAS2R38 (0.45) SMN1; SMN2TAS2R38NAPRTHSD17B10KMT2A
SCHEMBL109209 0.63 ALDH1A1 (0.43) SMN1; SMN2TAS2R38NAPRTHSD17B10MEN1
SCHEMBL1792956 0.63 ALDH1A1 (0.43) SMN1; SMN2TAS2R38NAPRTHSD17B10MEN1
SCHEMBL14868330 0.62 TAS2R38 (0.41) SMN1; SMN2CYP1A2TAS2R38NAPRTHSD17B10
SCHEMBL9505592 0.62 TAS2R38 (0.48) SMN1; SMN2CYP1A2TAS2R38NAPRTHSD17B10
SCHEMBL19176502 0.61 MAPT (0.53) SMN1; SMN2TGM2CYP1A2TAS2R38NAPRT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3156394-B1 ALKYLIDENE AMINOGANIDINE AND SALT THEREOF, MODIFIER COMPOSITION, MODIFIED RUBBER FOR TIRE, RUBBER COMPOSITION FOR TIRE, AND TIRE MITSUBISHI GAS CHEMICAL CO (JP) 2019-04-17 — — EP disclosed
US-10173973-B2 Alkylidene aminoguanidine and salt thereof, modifying composition, modified rubber for tire, rubber composition for tire, and tire MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2019-01-08 — — US disclosed
US-20170129850-A1 ALKYLIDENE AMINOGUANIDINE AND SALT THEREOF, MODIFYING COMPOSITION, MODIFIED RUBBER FOR TIRE, RUBBER COMPOSITION FOR TIRE, AND TIRE MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2017-05-11 — — US disclosed
EP-3156394-A1 ALKYLIDENE AMINOGANIDINE AND SALT THEREOF, MODIFIER COMPOSITION, MODIFIED RUBBER FOR TIRE, RUBBER COMPOSITION FOR TIRE, AND TIRE Mitsubishi Gas Chemical Company, Inc. (JP) 2017-04-19 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170129850-A1 ALKYLIDENE AMINOGUANIDINE AND SALT THEREOF, MODIFYING COMPOSITION, MODIFIED RUBBER FOR TIRE, RUBBER COMPOSITION FOR TIRE, AND TIRE TAAR1, PRMT9, RASGRP1 SMN1; SMN2 589/4885TGM2 1255/4885CYP1A2 1588/4885
US-10173973-B2 Alkylidene aminoguanidine and salt thereof, modifying composition, modified rubber for tire, rubber composition for tire, and tire TAAR1, PRMT9, RASGRP1 SMN1; SMN2 589/4885TGM2 1255/4885CYP1A2 1588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback